CTOs on the Move

Roadmunk

www.roadmunk.com

 
Roadmunk was inspired by a problem our founders experienced personally: there was no simple way for product managers to build, share and align on the roadmap. As we got to know our users, we discovered that roadmapping is not one-size-fits-all. Companies make roadmaps of all shapes, sizes and types—it`s a powerful and essential tool for alignment. Our goal is to make strategic roadmapping quick, effective and collaborative across an entire organization.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Alcosys Inc

Alcosys Inc is a Arlington, VA-based company in the Computers and Electronics sector.

S.O.S.

S.O.S. is a Chardon, OH-based company in the Computers and Electronics sector.

Keno Kozie

Keno Kozie is a Chicago, IL-based company in the Computers and Electronics sector.

BTCC

BTCC was originally founded as BTCChina in 2011. It was China’s first bitcoin exchange, and is now the longest-running and amongst the largest in the world. Today, BTCC plays a leading role in every segment of the bitcoin ecosystem, offering a digital currency exchange, a mining pool, payment processing, consumer wallets, and blockchain engraving. These diverse products and services offered by BTCC allow its global customers to engage in all aspects of the digital currency spectrum, in one integrated platform. Headquartered in Shanghai, China, BTCC serves a global customer base and has become an industry leader for security, risk mitigation, credibility, and technological innovation. BTCC’s mission is to provide the world with the most convenient and trustworthy digital currency services.

SolveBio

SolveBio equips you with Genomic Intelligence to guide you through a complex world towards innovation and discovery — driving precision medicine, advancing human health. Today, enterprises that endeavor to utilize genomics must navigate the ever-changing world of data, studies, and expert opinions. No matter the credibility of their sources or strength of their models, these will often conflict, simply because human biology and scientific discovery are dynamic and complex. To mainstream precision medicine, life science enterprises need to convert the complexity of biology into an easily distributed, readily deployed information asset. We call this Genomic Intelligence.